Xpress Genomics
PrivateCompany Overview
Xpress Genomics operates in Healthcare & Life Sciences and is based in Solna. It was founded in 2022.
Xpress Genomics is a biotechnology company that provides scalable and high-quality genomics services, specializing in single-cell RNA-sequencing for researchers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xpress Genomics Comparables
Compare Xpress Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Single Cell Discoveries | 86% | |
| SingulOmics Corporation | 84% | |
| Admera Health | 83% |
For institutional investors. Book with your work email.
Xpress Genomics Funding Rounds
Historical fundraising activity
Xpress Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xpress Genomics's valuation, stock price, and market status.
Is Xpress Genomics a public or private company?
Xpress Genomics is a private company.
What is the current stock price of Xpress Genomics?
Xpress Genomics is a private company, so its shares have no public market price. Caplight tracks Xpress Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xpress Genomics worth (valuation)?
Valuation information for Xpress Genomics is not publicly available.
Can I buy Xpress Genomics stock?
Xpress Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xpress Genomics's last funding round?
Funding round information for Xpress Genomics is not publicly available.
Who are the main investors in Xpress Genomics?
Investor information for Xpress Genomics is not publicly disclosed.
Will Xpress Genomics IPO soon?
No public IPO plans have been announced for Xpress Genomics.
How can I track Xpress Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Xpress Genomics's shares on secondary markets.